Kronox Lab Sciences Ltd (KRONOX) is currently trading at 193.55 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Kronox Lab Sciences Limited manufactures high-purity specialty fine, inorganic, metallic and phosphate chemicals used across pharmaceuticals, nutraceuticals, solar, biotech, agrochemical, personal care, metal refining and animal health industries from two manufacturing units; their products serve as reacting agents, excipients, reagents and process intermediates critical to API manufacture, research labs and specialty industrial processes. In FY2026 Kronox reported revenue from operations of Rs.10,122.00 lakhs and total income of Rs.10,641.40 lakhs, producing profit before tax of Rs.3,730.30 lakhs and profit after tax of Rs.2,766.00 lakhs; these results show robust profitability and marginal top-line growth year-on-year, delivering unusually high operating margins for a mid-sized specialty chemicals manufacturer. During FY2026 the company invested Rs.2,450.9 lakhs in property, plant and equipment while generating net cash from operations of Rs.2,389.25 lakhs, indicating simultaneous strong operating cash generation and material capital deployment to expand manufacturing capacity; reported borrowings remained modest and capital work-in-progress increased, consistent with an organic capacity expansion strategy. Kronox completed a public listing process in June 2024 via an offer for sale, improving market visibility; the Board declared a final dividend of 5% for 2025–26 and statutory auditors issued an unmodified opinion on the FY2026 audited results, while total equity rose to Rs.7,902.3 lakhs, strengthening the company’s public-financial profile and investor credibility.

Over the past 52 weeks, Kronox Lab Sciences Ltd has traded between a low of ₹96.00 and a high of ₹226.50. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Kronox Lab Sciences Ltd has a market capitalization of approximately 716.11. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Kronox Lab Sciences Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 25.28 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 716.11 Cr, Kronox Lab Sciences Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Kronox Lab Sciences Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Kronox Lab Sciences Ltd is 25.28. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Indo Borax acquired 2,38,44,000 Kronox equity shares, representing 64.26% of paid-up equity share capital. The transaction was completed on September 29, 2026, and the filing states that it gave Indo Borax sole control.

Indo Borax and Chemicals has offered ₹157.27 in cash for each Kronox Lab Sciences equity share tendered under the open offer. The offer seeks up to 95.70 lakh shares from public shareholders.

Kronox’s IDC unanimously concluded on November 2, 2026 that the Rs 157.27-per-share offer was fair and reasonable. The committee said the price complied with the applicable takeover regulations after reviewing the offer documents.

Indo Borax and Chemicals Limited and Zenrock Chemicals Private Limited are offering ₹157.27 in cash for each Kronox Lab Sciences Limited equity share tendered. The offer covers up to 95.70 lakh shares.